- 現金殖利率: 3.51%、總殖利率: 7.22%、5年平均現金配發率: 47.88%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 1.01 | -7.34 | 0.60 | 17.65 | 0.40 | -4.76 | 59.41 | 26.97 | 39.60 | 2.78 | 99.01 | 16.04 |
2022 (9) | 1.09 | -33.13 | 0.51 | -16.39 | 0.42 | -16.0 | 46.79 | 25.03 | 38.53 | 25.61 | 85.32 | 25.29 |
2021 (8) | 1.63 | 39.32 | 0.61 | 8.93 | 0.50 | 11.11 | 37.42 | -21.81 | 30.67 | -20.25 | 68.10 | -21.11 |
2020 (7) | 1.17 | -1.68 | 0.56 | -1.75 | 0.45 | 95.65 | 47.86 | -0.07 | 38.46 | 99.0 | 86.32 | 28.41 |
2019 (6) | 1.19 | 9.17 | 0.57 | 11.76 | 0.23 | 9.52 | 47.90 | 2.37 | 19.33 | 0.32 | 67.23 | 1.77 |
2018 (5) | 1.09 | -5.22 | 0.51 | -5.56 | 0.21 | -52.27 | 46.79 | -0.36 | 19.27 | -49.65 | 66.06 | -22.49 |
2017 (4) | 1.15 | 0.88 | 0.54 | 1.89 | 0.44 | 2.33 | 46.96 | 1.0 | 38.26 | 1.44 | 85.22 | 1.2 |
2016 (3) | 1.14 | -17.39 | 0.53 | 10.42 | 0.43 | -40.28 | 46.49 | 33.66 | 37.72 | -27.7 | 84.21 | -3.16 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.43 | 10.26 | 95.45 | 0.43 | 10.26 | 86.96 | 1.17 | 58.11 | 37.65 |
24Q2 (19) | 0.39 | 8.33 | 44.44 | 0.39 | 11.43 | 44.44 | 0.74 | 105.56 | 17.46 |
24Q1 (18) | 0.36 | 125.0 | -5.26 | 0.35 | 94.44 | -2.78 | 0.36 | -64.36 | -5.26 |
23Q4 (17) | 0.16 | -27.27 | -68.63 | 0.18 | -21.74 | -61.7 | 1.01 | 18.82 | -7.34 |
23Q3 (16) | 0.22 | -18.52 | -21.43 | 0.23 | -14.81 | -14.81 | 0.85 | 34.92 | 46.55 |
23Q2 (15) | 0.27 | -28.95 | 58.82 | 0.27 | -25.0 | 68.75 | 0.63 | 65.79 | 96.88 |
23Q1 (14) | 0.38 | -25.49 | 153.33 | 0.36 | -23.4 | 140.0 | 0.38 | -65.14 | 153.33 |
22Q4 (13) | 0.51 | 82.14 | 183.33 | 0.47 | 74.07 | 161.11 | 1.09 | 87.93 | -33.13 |
22Q3 (12) | 0.28 | 64.71 | -28.21 | 0.27 | 68.75 | -20.59 | 0.58 | 81.25 | -60.0 |
22Q2 (11) | 0.17 | 13.33 | -77.03 | 0.16 | 6.67 | -73.33 | 0.32 | 113.33 | -71.17 |
22Q1 (10) | 0.15 | -16.67 | -59.46 | 0.15 | -16.67 | -53.12 | 0.15 | -90.8 | -59.46 |
21Q4 (9) | 0.18 | -53.85 | -14.29 | 0.18 | -47.06 | -5.26 | 1.63 | 12.41 | 39.32 |
21Q3 (8) | 0.39 | -47.3 | 0.0 | 0.34 | -43.33 | 3.03 | 1.45 | 30.63 | 51.04 |
21Q2 (7) | 0.74 | 100.0 | 94.74 | 0.60 | 87.5 | 87.5 | 1.11 | 200.0 | 94.74 |
21Q1 (6) | 0.37 | 76.19 | 85.0 | 0.32 | 68.42 | 77.78 | 0.37 | -68.38 | 85.0 |
20Q4 (5) | 0.21 | -46.15 | 5.0 | 0.19 | -42.42 | 5.56 | 1.17 | 21.87 | -1.68 |
20Q3 (4) | 0.39 | 2.63 | 0.0 | 0.33 | 3.13 | 0.0 | 0.96 | 68.42 | 0.0 |
20Q2 (3) | 0.38 | 90.0 | 0.0 | 0.32 | 77.78 | 0.0 | 0.57 | 185.0 | 0.0 |
20Q1 (2) | 0.20 | 0.0 | 0.0 | 0.18 | 0.0 | 0.0 | 0.20 | -83.19 | 0.0 |
19Q4 (1) | 0.20 | 0.0 | 0.0 | 0.18 | 0.0 | 0.0 | 1.19 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 71.48 | 8.71 | 15.68 | 800.13 | 23.61 | 208.34 | N/A | 0.11 | 1.62 | - |
2024/10 | 65.75 | -7.52 | 25.13 | 728.65 | 24.45 | 225.11 | N/A | 0.11 | 1.51 | - |
2024/9 | 71.1 | -19.42 | 108.24 | 662.9 | 24.38 | 234.81 | 0.0 | 0.12 | 1.4 | 去年創投子公司投資之興櫃股票上市,所造成評價變動較大 |
2024/8 | 88.25 | 16.96 | 37.9 | 591.8 | 18.64 | 243.7 | 0.0 | 0.23 | 1.28 | - |
2024/7 | 75.45 | -5.68 | 13.5 | 503.55 | 15.81 | 222.89 | 0.0 | 0.16 | 1.05 | - |
2024/6 | 80.0 | 18.61 | 26.44 | 428.09 | 16.23 | 213.95 | 0.0 | 0.2 | 0.88 | - |
2024/5 | 67.44 | 1.41 | 11.56 | 348.1 | 14.11 | 198.16 | 0.0 | 0.11 | 0.69 | - |
2024/4 | 66.5 | 3.57 | 29.19 | 280.65 | 14.74 | 198.03 | 0.0 | 0.15 | 0.58 | - |
2024/3 | 64.21 | -4.61 | -0.13 | 214.15 | 10.88 | 214.15 | 0.0 | 0.1 | 0.36 | - |
2024/2 | 67.31 | -18.53 | 6.57 | 149.94 | 16.38 | 203.09 | 0.0 | 0.08 | 0.26 | - |
2024/1 | 82.63 | 55.47 | 25.82 | 82.63 | 25.82 | 197.57 | 0.0 | 0.18 | 0.18 | - |
2023/12 | 53.15 | -13.98 | 8.0 | 700.41 | 5.33 | 167.48 | 0.0 | 0.02 | 1.26 | - |
2023/11 | 61.79 | 17.59 | -2.41 | 647.26 | 5.12 | 148.48 | 0.0 | 0.12 | 1.24 | - |
2023/10 | 52.54 | 53.88 | -32.63 | 585.47 | 5.99 | 150.68 | 0.0 | 0.07 | 1.12 | - |
2023/9 | 34.15 | -46.64 | -38.32 | 532.93 | 12.34 | 164.61 | 0.0 | -0.03 | 1.06 | - |
2023/8 | 63.99 | -3.73 | 1.95 | 498.78 | 19.03 | 193.73 | 0.0 | 0.15 | 1.08 | - |
2023/7 | 66.47 | 5.07 | 45.15 | 434.79 | 22.04 | 190.19 | 0.0 | 0.18 | 0.94 | - |
2023/6 | 63.26 | 4.65 | 18.74 | 368.31 | 18.63 | 175.19 | 0.0 | 0.13 | 0.76 | - |
2023/5 | 60.45 | 17.44 | 37.06 | 305.05 | 18.61 | 176.22 | 0.0 | 0.12 | 0.63 | - |
2023/4 | 51.48 | -19.93 | 11.61 | 244.6 | 14.79 | 178.93 | 0.0 | 0.08 | 0.51 | - |
2023/3 | 64.29 | 1.79 | 15.46 | 193.12 | 15.67 | 193.12 | 0.0 | 0.15 | 0.42 | - |
2023/2 | 63.16 | -3.82 | 22.91 | 128.83 | 15.77 | 178.04 | 0.0 | 0.15 | 0.28 | - |
2023/1 | 65.67 | 33.45 | 9.64 | 65.67 | 9.64 | 178.19 | 0.0 | 0.12 | 0.12 | - |
2022/12 | 49.21 | -22.28 | -8.83 | 664.9 | 4.1 | 190.52 | 0.0 | 0.01 | 1.25 | - |
2022/11 | 63.32 | -18.81 | 5.92 | 615.7 | 5.29 | 196.67 | 0.0 | 0.17 | 1.24 | - |
2022/10 | 77.99 | 40.88 | 51.49 | 552.38 | 5.22 | 196.12 | 0.0 | 0.29 | 1.06 | 台新創投本期FVPL認列30億未實現評價利益 |
2022/9 | 55.36 | -11.79 | -6.73 | 474.38 | 0.19 | 163.92 | 0.0 | 0.12 | 0.78 | - |
2022/8 | 62.77 | 37.05 | -10.64 | 419.02 | 1.18 | 161.84 | 0.0 | 0.16 | 0.66 | - |
2022/7 | 45.79 | -14.04 | -27.49 | 356.26 | 3.59 | 143.18 | 0.0 | 0.07 | 0.5 | - |
2022/6 | 53.28 | 20.8 | -38.34 | 310.46 | 10.59 | 143.5 | 0.0 | 0.13 | 0.43 | - |
2022/5 | 44.1 | -4.36 | 33.42 | 257.18 | 32.35 | 145.91 | 0.0 | 0.04 | 0.3 | - |
2022/4 | 46.12 | -17.17 | 12.76 | 213.08 | 32.13 | 153.19 | 0.0 | 0.05 | 0.26 | - |
2022/3 | 55.68 | 8.36 | 32.32 | 166.96 | 38.72 | 166.96 | 0.0 | 0.07 | 0.21 | - |
2022/2 | 51.38 | -14.2 | 39.94 | 111.28 | 42.16 | 165.25 | 0.0 | 0.09 | 0.13 | - |
2022/1 | 59.89 | 10.96 | 44.12 | 59.89 | 44.12 | 173.64 | 0.0 | 0.04 | 0.04 | - |
2021/12 | 53.97 | -9.7 | 58.0 | 638.71 | 45.17 | 165.23 | 0.0 | 0.02 | 1.65 | 本年新增人壽子公司 |
2021/11 | 59.77 | 16.1 | 71.75 | 584.74 | 44.09 | 170.61 | 0.0 | 0.11 | 1.63 | 本年新增人壽子公司 |
2021/10 | 51.48 | -13.26 | 49.47 | 524.96 | 41.49 | 181.08 | 0.0 | 0.08 | 1.51 | - |
2021/9 | 59.36 | -15.49 | 50.22 | 473.48 | 40.68 | 192.76 | 0.0 | 0.1 | 1.44 | 本年新增人壽子公司 |
2021/8 | 70.24 | 11.21 | 81.17 | 414.12 | 39.41 | 219.81 | 0.0 | 0.16 | 1.33 | 本月認列彰銀股利收入7.7億 |
2021/7 | 63.16 | -26.91 | 52.73 | 343.88 | 33.14 | 182.63 | 0.0 | 0.16 | 1.17 | 本月新增人壽子公司 |
2021/6 | 86.41 | 161.41 | 114.84 | 280.72 | 29.4 | 160.37 | 0.0 | 0.43 | 1.01 | 本月處分彰銀部分持股並就剩餘持股重新評價,認列損失42.58億元,及取得保德信人壽100%股權認列暫定廉價購買利益91.86億元。 |
2021/5 | 33.06 | -19.18 | -11.28 | 194.31 | 9.96 | 116.04 | 0.0 | 0.07 | 0.58 | - |
2021/4 | 40.9 | -2.8 | 2.99 | 161.25 | 15.63 | 119.7 | 0.0 | 0.14 | 0.52 | - |
2021/3 | 42.08 | 14.6 | 75.8 | 120.35 | 20.67 | 120.35 | 0.0 | 0.14 | 0.37 | 本月增減百分比大於50%,係因109年3月受到新型冠狀病毒肺炎(COVID-19)疫情影響,全球金融市場大幅動盪;今年趨穩。 |
2021/2 | 36.72 | -11.64 | 3.06 | 78.27 | 3.26 | 112.43 | 0.0 | 0.11 | 0.23 | - |
2021/1 | 41.56 | 21.65 | 3.44 | 41.56 | 3.44 | 110.52 | 0.0 | 0.12 | 0.12 | - |
2020/12 | 34.16 | -1.84 | -2.65 | 439.96 | 0.67 | 103.4 | 0.0 | 0.02 | 1.17 | - |
2020/11 | 34.8 | 1.04 | 0.37 | 405.8 | 0.96 | 108.75 | 0.0 | 0.09 | 1.14 | - |
2020/10 | 34.44 | -12.82 | -6.81 | 371.0 | 1.02 | 112.72 | 0.0 | 0.09 | 1.05 | - |
2020/9 | 39.51 | 1.9 | 15.95 | 336.56 | 1.9 | 119.63 | 0.0 | 0.13 | 0.97 | - |
2020/8 | 38.77 | -6.23 | 5.71 | 297.05 | 0.28 | 120.34 | 0.0 | 0.11 | 0.84 | - |
2020/7 | 41.35 | 2.8 | 1.35 | 258.28 | -0.48 | 118.83 | 0.0 | 0.13 | 0.73 | - |
2020/6 | 40.22 | 7.94 | 8.49 | 216.93 | -0.82 | 117.19 | 0.0 | 0.14 | 0.59 | - |
2020/5 | 37.26 | -6.16 | 4.31 | 176.71 | -2.72 | 100.91 | 0.0 | 0.11 | 0.46 | - |
2020/4 | 39.71 | 65.89 | 12.89 | 139.45 | -4.44 | 99.27 | 0.0 | 0.12 | 0.35 | - |
2020/3 | 23.94 | -32.81 | -34.82 | 99.74 | -9.95 | 99.74 | 0.0 | -0.0 | 0.22 | - |
2020/2 | 35.63 | -11.31 | 14.66 | 75.8 | 2.38 | 110.89 | 0.0 | 0.1 | 0.23 | - |
2020/1 | 40.17 | 14.48 | -6.49 | 40.17 | -6.49 | 0.0 | N/A | 0.13 | 0.13 | - |
2019/12 | 35.09 | 1.21 | 24.33 | 437.0 | 9.79 | 0.0 | N/A | 0.04 | 1.16 | - |